RB 6145

RB 6145 is a bifunctional nitroimidazole prodrug of the radiosensitizer RSU 1069, exhibiting reduced systemic toxicity. It demonstrates selective cytotoxicity under hypoxic conditions and has shown antitumor activity in experimental models, supporting its research in radiobiology and oncology for both in vitro and in vivo studies.